Corneal Lymphatics & Adaptive Immunity
Corneal Lymphatics & Adaptive Immunity
批准号:
8386499
负责人:
DANIEL J CARR
金额:
$34.95万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-12-01 至 2015-11-30
关键词:
AcuteAddressAntibodiesAntigensAttenuatedBloodCD8B1 geneCellsCorneaDevelopmentEffector CellGenerationsGoalsHerpesvirus 1Herpetic KeratitisImmuneImmune responseInfectionInflammation MediatorsInflammatoryKeratitisKeratoplastyLeadLeukocyte TraffickingLymphangiogenesisLymphaticLymphatic vesselMaintenanceMediatingMonitorMusOcular PathologyPathogenesisPathologyPathway interactionsProcessProductionRelative (related person)RoleSeveritiesT cell responseTestingTherapeutic InterventionVascular Endothelial Growth Factor AVascular Endothelial Growth Factor CVascular Endothelial Growth Factor ReceptorVascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth Factor Receptor-3ViralVirusVisualadaptive immunitychemokinecorneal epitheliumcytokinedriving forcelymph nodesmacrophagemonocytemouse modelneovascularizationresponsetraffickingtreatment strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Neovascularization in the normally avascular cornea can lead to a compromised visual axis.
Within the term "neovascularization" is a blood component referred to as hemangiogenesis and
a lymphatic component referred to as lymphangiogenesis. Relative to herpes simplex virus type
1 (HSV-1) infection, only hemangiogenesis has been investigated. Recently, we have initiated a
study on lymphangiogenesis following corneal infection with HSV-1 and discovered this process
precedes hemangiogenesis. More importantly, we have discovered the genesis of lymphatic
vessels in the cornea proper in response to HSV-1 infection operates thru a unique pathway
distinct from what has been described following corneal transplantation. Specifically, we have
found a robust vascular endothelial growth factor (VEGF) A response by corneal epithelium
infected with HSV-1 elicits lymphangiogenesis thru a VEGF receptor 2 (VEGFR2)-mediated
pathway. This process is independent of VEGF C, VEGF receptor 3, or
monocytes/macrophages. We have also found the newly created lymphatic vessels are
capable of transporting soluble antigen to the draining lymph node independent of
hemangiogenesis. However, what remains unknown is the contribution of the newly created
lymphatic conduit to the host immune response within the draining lymph node as well as other
inflammatory mediators that contribute to corneal lymphangiogenesis. We hypothesize
lymphatic vessel development driven principally by VEGF A and contributing pro-inflammatory
molecules generated locally in response to infection are critical for the induction of the adaptive
immune response found in the draining lymph node reflected by the severity in the development
of herpetic stromal keratitis of HSV-1 infected mice. To address this hypothesis, two specific
aims are proposed: Specific aim 1 will address the impact of viral replication and pro-
inflammatory cytokine expression on corneal lymphangiogenesis following HSV-1 infection. In
addition, trafficking of leukocyte subpopulations and antigen will be monitored as well. Specific
aim 2 will address the significance of lymphangiogenesis relative to the genesis of the adaptive
immune response in the draining lymph node and development of stromal keratitis following
HSV-1 infection. It will further address the role of virus-induced VEGF A production on the
production of CD4+ and CD8+ T effector cells that contribute in viral surveillance and corneal
pathogenesis. It is anticipated in accomplishing these goals, we will eludicate the contribution of
pro-lymphangiogenesis factors in the generation of the adaptive immune response critical for
the ocular pathology that includes the debilitating and sometimes blinding stromal keratitis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cellular & Molecular Cascades in Vision Research
-
批准号:8853282
-
项目类别:
-
资助金额:$14.2万
-
财政年份:2014
-
负责人:DANIEL J CARR
-
依托单位:
Cellular & Molecular Cascades in Vision Research
-
批准号:8662545
-
项目类别:
-
资助金额:$14.0万
-
财政年份:2014
-
负责人:DANIEL J CARR
-
依托单位:
Genotyping Core
-
批准号:10011812
-
项目类别:
-
资助金额:$11.49万
-
财政年份:2011
-
负责人:DANIEL J CARR
-
依托单位:
Corneal Lymphatics & Adaptive Immunity
-
批准号:8922184
-
项目类别:
-
资助金额:$15.51万
-
财政年份:2010
-
负责人:DANIEL J CARR
-
依托单位:
Corneal Lymphatics & Adaptive Immunity
-
批准号:8025043
-
项目类别:
-
资助金额:$36.79万
-
财政年份:2010
-
负责人:DANIEL J CARR
-
依托单位:
Corneal Lymphatics & Adaptive Immunity
-
批准号:8585853
-
项目类别:
-
资助金额:$36.06万
-
财政年份:2010
-
负责人:DANIEL J CARR
-
依托单位:
Corneal Lymphatics & Adaptive Immunity
-
批准号:8204539
-
项目类别:
-
资助金额:$36.79万
-
财政年份:2010
-
负责人:DANIEL J CARR
-
依托单位:
Corneal Lymphatics & Adaptive Immunity
-
批准号:9181424
-
项目类别:
-
资助金额:$33.08万
-
财政年份:2010
-
负责人:DANIEL J CARR
-
依托单位:
Ocular Lymphangiogenesis
-
批准号:7590207
-
项目类别:
-
资助金额:$18.21万
-
财政年份:2009
-
负责人:DANIEL J CARR
-
依托单位:
Ocular Lymphangiogenesis
-
批准号:7744640
-
项目类别:
-
资助金额:$18.02万
-
财政年份:2009
-
负责人:DANIEL J CARR
-
依托单位:
The Role of CXCL9 in Genital HSV-2 Infection
-
批准号:7624586
-
项目类别:
-
资助金额:$28.64万
-
财政年份:2007
-
负责人:DANIEL J CARR
-
依托单位:
The Role of CXCL9 in Genital HSV-2 Infection
-
批准号:7305579
-
项目类别:
-
资助金额:$26.87万
-
财政年份:2007
-
负责人:DANIEL J CARR
-
依托单位:
The Role of CXCL9 in Genital HSV-2 Infection
-
批准号:7457966
-
项目类别:
-
资助金额:$28.64万
-
财政年份:2007
-
负责人:DANIEL J CARR
-
依托单位:
Anti-Viral Gene Delivery in the Nervous System
-
批准号:6757751
-
项目类别:
-
资助金额:$18.31万
-
财政年份:2004
-
负责人:DANIEL J CARR
-
依托单位:
Anti-Viral Gene Delivery in the Nervous System
-
批准号:6875563
-
项目类别:
-
资助金额:$18.31万
-
财政年份:2004
-
负责人:DANIEL J CARR
-
依托单位:
The Neuroimmunology of Viral Infection
-
批准号:7393823
-
项目类别:
-
资助金额:$27.91万
-
财政年份:2003
-
负责人:DANIEL J CARR
-
依托单位:
The Neuroimmunology of Viral Infection
-
批准号:8286147
-
项目类别:
-
资助金额:$36.79万
-
财政年份:2003
-
负责人:DANIEL J CARR
-
依托单位:
The Neuroimmunology of Viral Infection
-
批准号:6556505
-
项目类别:
-
资助金额:$21.98万
-
财政年份:2003
-
负责人:DANIEL J CARR
-
依托单位:
The Neuroimmunology of Viral Infection
-
批准号:6877705
-
项目类别:
-
资助金额:$21.98万
-
财政年份:2003
-
负责人:DANIEL J CARR
-
依托单位:
The Neuroimmunology of Viral Infection
-
批准号:6727496
-
项目类别:
-
资助金额:$21.98万
-
财政年份:2003
-
负责人:DANIEL J CARR
-
依托单位:
海外基金